Skip to main content

previous disabled Page of 4
and
  1. No Access

    Article

    Magnesium supplementation therapy to prevent cisplatin-induced acute nephrotoxicity in pediatric cancer: a randomized phase-2 trial

    The present study aimed to examine the effect of magnesium (Mg) supplementation on cisplatin-induced nephrotoxicity (CIN) in pediatric cancer patients.

    Motohiro Matsui, Atsushi Makimoto in International Journal of Clinical Oncology (2024)

  2. Article

    Open Access

    A higher CD34 + cell dose correlates with better event-free survival after KIR-ligand mismatched cord blood transplantation for childhood acute myeloid leukemia

    Although killer Ig-like receptor ligands (KIR-L) mismatch has been associated with alloreactive natural killer cell activity and potent graft-versus-leukemia (GVL) effect among adults with acute myeloid leukem...

    Hisashi Ishida, Yuta Kawahara, Daisuke Tomizawa in Journal of Hematology & Oncology (2024)

  3. No Access

    Article

    Nelarabine-containing salvage therapy and conditioning regimen in transplants for pediatric T-cell acute lymphoblastic leukemia and lymphoma

    Therapy for relapsed or refractory (r/r) T-cell acute lymphoblastic leukemia (T-ALL) and T-cell lymphoblastic lymphoma (T-LBL) in children is challenging, and new treatment methods are needed. We retrospective...

    Masato Yanagi, Makiko Mori, Mamoru Honda in International Journal of Hematology (2024)

  4. No Access

    Article

    Early chemotherapeutic intervention to avoid thyroidectomy in pediatric Langerhans cell histiocytosis with thyroid involvement accompanying tracheal stenosis: a report of two cases

    Thyroid involvement is rare in pediatric Langerhans cell histiocytosis (LCH). It may cause airway narrowing, leading to acute-onset respiratory distress. Severe cases may require emergent surgical intervention...

    Shuhei Aoyama, Kohei Fukuoka, Hirohito Kubota in International Journal of Hematology (2024)

  5. No Access

    Article

    High-dose cytarabine induction therapy and flow cytometric measurable residual disease monitoring for children with acute myeloid leukemia

    Daisuke Tomizawa, Jun Matsubayashi, Shotaro Iwamoto, Hidefumi Hiramatsu in Leukemia (2024)

  6. Article

    Open Access

    Subty** of Group 3/4 medulloblastoma as a potential prognostic biomarker among patients treated with reduced dose of craniospinal irradiation: a Japanese Pediatric Molecular Neuro-Oncology Group study

    One of the most significant challenges in patients with medulloblastoma is reducing the dose of craniospinal irradiation (CSI) to minimize neurological sequelae in survivors. Molecular characterization of pati...

    Kohei Fukuoka, Jun Kurihara, Tomoko Shofuda in Acta Neuropathologica Communications (2023)

  7. No Access

    Article

    Molecular characterization of long-term survivors of metastatic medulloblastoma treated with reduced-dose craniospinal irradiation

    Current standard treatment for metastatic medulloblastoma consists of 36 Gray (Gy) of craniospinal irradiation (CSI) supplemented with local irradiation and adjuvant chemotherapy after surgery. Although contem...

    Tomoya Irikura, Kohei Fukuoka, Atsuko Nakazawa, Koichi Ichimura in Child's Nervous System (2023)

  8. No Access

    Article

    Outcomes following induction failure in Japanese children with acute lymphoblastic leukemia

    The characteristics and prognosis of Japanese children with acute lymphoblastic leukemia (ALL) who fail to achieve complete remission after remission induction chemotherapy (i.e., experience induction failure)...

    Chihaya Imai, Atsushi Sato, Mitsuteru Hiwatari in International Journal of Hematology (2023)

  9. No Access

    Article

    Intensification of treatment with vinca alkaloid does not improve outcomes in pediatric patients with Langerhans cell histiocytosis: results from the JPLSG LCH-12 study

    Chemotherapy with cytarabine, vincristine (VCR), and prednisolone has achieved low mortality rates in pediatric patients with Langerhans cell histiocytosis (LCH). However, relapse rates remain high, making eve...

    Akira Morimoto, Yoko Shioda, Kazuko Kudo in International Journal of Hematology (2023)

  10. No Access

    Article

    Optimal timing of liver transplantation for liver cirrhosis caused by sclerosing cholangitis in a patient with Langerhans cell histiocytosis: a case report

    Liver cirrhosis due to secondary sclerosing cholangitis caused by Langerhans cell histiocytosis (LCH) has a poor prognosis, and liver transplantation is the definitive treatment. However, the optimal timing ha...

    Mai Watakabe, Kohei Fukuoka, Yoshiyuki Ihara in International Journal of Hematology (2023)

  11. No Access

    Article

    Long-term efficacy and safety profile of splenectomy for pediatric chronic immune thrombocytopenia

    There are few reports of the long-term efficacy of splenectomy in children with immune thrombocytopenia (ITP). In a 33-year period, we performed splenectomies in 23 pediatric patients with ITP at a single inst...

    Kyohei Isshiki, Makiko Mori, Tomoya Irikura in International Journal of Hematology (2023)

  12. Article

    Open Access

    Identification of the ultrahigh-risk subgroup in neuroblastoma cases through DNA methylation analysis and its treatment exploiting cancer metabolism

    Neuroblastomas require novel therapies that are based on the exploitation of their biological mechanism. To address this need, we analyzed the DNA methylation and expression datasets of neuroblastomas, extract...

    Kentaro Watanabe, Shunsuke Kimura, Masafumi Seki, Tomoya Isobe, Yasuo Kubota in Oncogene (2022)

  13. Article

    Open Access

    Multi-omics analysis defines highly refractory RAS burdened immature subgroup of infant acute lymphoblastic leukemia

    KMT2A-rearranged infant acute lymphoblastic leukemia (ALL) represents the most refractory type of childhood leukemia. To uncover the molecular heterogeneity of this disease, we perform RNA sequencing, methylation...

    Tomoya Isobe, Masatoshi Takagi, Aiko Sato-Otsubo, Akira Nishimura in Nature Communications (2022)

  14. Article

    Correction to: Post-induction MRD by FCM and GATA1-PCR are significant prognostic factors for myeloid leukemia of Down syndrome

    Takashi Taga, Shiro Tanaka, Daisuke Hasegawa, Kiminori Terui, Tsutomu Toki in Leukemia (2021)

  15. No Access

    Article

    Effect of high-dose chemotherapy plus stem cell rescue on the survival of patients with neuroblastoma modified by MYCN gene gain/amplification and remission status: a nationwide registration study in Japan

    In high-risk neuroblastoma, the presence of an MYCN gain/amplification (MYCN-GA) is not always a risk factor of cancer-specific death. We herein examined the effect modification of high-dose chemotherapy with ...

    Yuya Saito, Mitsuyoshi Urashima, Yoshiyuki Takahashi in Bone Marrow Transplantation (2021)

  16. No Access

    Article

    Post-induction MRD by FCM and GATA1-PCR are significant prognostic factors for myeloid leukemia of Down syndrome

    Myeloid leukemia of Down syndrome (ML-DS) is associated with good response to chemotherapy, resulting in favorable outcomes. However, no universal prognostic factors have been identified to date. To clarify a ...

    Takashi Taga, Shiro Tanaka, Daisuke Hasegawa, Kiminori Terui, Tsutomu Toki in Leukemia (2021)

  17. No Access

    Article

    Asian population may have a lower incidence of hip osteonecrosis in childhood acute lymphoblastic leukemia

    Osteonecrosis (ON), a long-term complication of acute lymphoblastic leukemia (ALL) treatment affects patients’ quality of life. Although the incidence of any ON, including asymptomatic, was 21.7% among childre...

    Yuki Arakawa, Satoshi Masutani, Koichi Oshima in International Journal of Hematology (2021)

  18. No Access

    Article

    Effect of extramedullary disease on allogeneic hematopoietic cell transplantation for pediatric acute myeloid leukemia: a nationwide retrospective study

    Children with acute myeloid leukemia (AML) commonly develop extramedullary disease (EMD), which comprises central nervous system (CNS) lesions and myeloid sarcoma (MS). In this retrospective analysis, we aimed...

    Hirotoshi Sakaguchi, Takako Miyamura, Daisuke Tomizawa in Bone Marrow Transplantation (2021)

  19. No Access

    Article

    Clot waveform analysis for perioperative hemostatic monitoring of arthroscopic synovectomy in a pediatric patient with hemophilia A and inhibitor receiving emicizumab prophylaxis

    Emicizumab reduces bleeding in patients with hemophilia A and inhibitors (PwHA-I). Coagulation potential during the perioperative period in emicizumab-treated PwHA-I undergoing surgery remains to be evaluated....

    Kuniyoshi Mizumachi, Yusuke Tsumura, Yuto Nakajima in International Journal of Hematology (2021)

  20. Article

    Open Access

    Predictive factors for the development of leukemia in patients with transient abnormal myelopoiesis and Down syndrome

    Genki Yamato, Takao Deguchi, Kiminori Terui, Tsutomu Toki, Tomoyuki Watanabe in Leukemia (2021)

previous disabled Page of 4